Pfizer Inc. continues to give signals that the grand plan is to break itself up, and the reality looks like it absolutely needs AstraZeneca plc's assets to make it work.

Pfizer already has internally organized itself into three business units, and has been hinting at a breakup scenario for months. Last week it honed the narrative down further, telling investors that should the breakup occur, it would become two companies.